India
Government caps trade margins on 137 anti-cancer drugs; steepest price cut is 96%
The cap of 30% on trade margins took effect on 9 November and is expected to save about ₹3,557 crore a year.
In short
96%steepest reported price cut
- 137 medicines covered
- Trade margin cap: 30%
- Estimated savings: ₹3,557 crore a year
What changed
The government has capped trade margins at 30% on 137 non-scheduled anti-cancer medicines, effective 9 November. The aim is to curb excessive mark-ups by manufacturers, distributors and pharmacies.
How much will you save?
Reported price cuts range from about 20% to 70% on average, with the steepest at 96.45%. The estimated saving is about ₹3,557 crore a year, based on FY26 sales volumes. The source does not list the specific drugs, so patients should ask their pharmacist or hospital which products are covered.
Read the original reporting
Business Today↗
